On December 23, 2025, Genprex, Inc. reported it believes it meets Nasdaq’s stockholders’ equity requirement, following proceeds from recent offerings, but compliance is still pending confirmation from Nasdaq. Previously, on August 19, 2025, Nasdaq indicated the company was not in compliance with this requirement.